Skip to content
CancerIndex

Ranking · Unmet Need

Trial Gap Index

Burden percentile minus active-trial percentile within the same scope. Positive values flag cancers with high mortality burden but comparatively few active trials. A quantitative signal, not an accusation (CLAUDE.md §324). Caveat (Phase 1): trial counts aggregate a cancer and its NCIt descendants only; registrations phrased at a broader level (e.g. "colorectal cancer" for colon and rectal cancer) are attributed to the broader entity, which can overstate the gap of narrower top-level sites.

Computedci-trial-gap-v1unit: percentile pointshigher = worseAll metrics

Top 15 by Trial Gap IndexMalignant Colon Neoplasm+50Malignant Bladder Neoplasm+23.3Cutaneous Melanoma+20Malignant Laryngeal Neoplasm+16.7Malignant Pancreatic Neoplasm+16.7Malignant Rectal Neoplasm+10Malignant Vulvar Neoplasm+10Malignant Kidney Neoplasm+6.6Malignant Esophageal Neoplasm+3.4Malignant Anal Neoplasm+3.4Malignant Salivary Gland Neop…+3.3Malignant Testicular Neoplasm+3.3Malignant Vaginal Neoplasm+3.3Malignant Liver Neoplasm0Malignant Lung Neoplasm0
RankΔCancerTrial Gap Index (percentile points)PercentileConfidenceSourcesWhy #n?
1=Malignant Colon Neoplasm+50100Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
40880
formula
percentile(mortality_count) − percentile(active_trials)
activity
225
burdenPercentile
90
activityPercentile
40

ranking row 2607938

2▲2Malignant Bladder Neoplasm+23.396.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
17317
formula
percentile(mortality_count) − percentile(active_trials)
activity
346
burdenPercentile
70
activityPercentile
46.7

ranking row 2607939

3=Cutaneous Melanoma+2093.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8350
formula
percentile(mortality_count) − percentile(active_trials)
activity
78
burdenPercentile
46.7
activityPercentile
26.7

ranking row 2607940

4▲1Malignant Laryngeal Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
3914
formula
percentile(mortality_count) − percentile(active_trials)
activity
66
burdenPercentile
36.7
activityPercentile
20

ranking row 2607942

4▲2Malignant Pancreatic Neoplasm+16.790Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
49451
formula
percentile(mortality_count) − percentile(active_trials)
activity
904
burdenPercentile
96.7
activityPercentile
80

ranking row 2607941

6▲2Malignant Rectal Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12899
formula
percentile(mortality_count) − percentile(active_trials)
activity
386
burdenPercentile
60
activityPercentile
50

ranking row 2607944

6▲4Malignant Vulvar Neoplasm+1083.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1474
formula
percentile(mortality_count) − percentile(active_trials)
activity
54
burdenPercentile
23.3
activityPercentile
13.3

ranking row 2607943

8▲3Malignant Kidney Neoplasm+6.676.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
14777
formula
percentile(mortality_count) − percentile(active_trials)
activity
453
burdenPercentile
63.3
activityPercentile
56.7

ranking row 2607945

9▲3Malignant Esophageal Neoplasm+3.473.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
16052
formula
percentile(mortality_count) − percentile(active_trials)
activity
518
burdenPercentile
66.7
activityPercentile
63.3

ranking row 2607946

10▲4Malignant Anal Neoplasm+3.470Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1601
formula
percentile(mortality_count) − percentile(active_trials)
activity
68
burdenPercentile
26.7
activityPercentile
23.3

ranking row 2607947

11▲3Malignant Salivary Gland Neoplasm+3.366.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1114
formula
percentile(mortality_count) − percentile(active_trials)
activity
63
burdenPercentile
20
activityPercentile
16.7

ranking row 2607948

12▲2Malignant Testicular Neoplasm+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
537
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
10
activityPercentile
6.7

ranking row 2607949

12▲1Malignant Vaginal Neoplasm+3.363.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
438
formula
percentile(mortality_count) − percentile(active_trials)
activity
31
burdenPercentile
3.3
activityPercentile
0

ranking row 2607950

14=Malignant Liver Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
29911
formula
percentile(mortality_count) − percentile(active_trials)
activity
906
burdenPercentile
83.3
activityPercentile
83.3

ranking row 2607953

14=Malignant Lung Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
131584
formula
percentile(mortality_count) − percentile(active_trials)
activity
2644
burdenPercentile
100
activityPercentile
100

ranking row 2607952

14▲7Malignant Mesothelioma056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2127
formula
percentile(mortality_count) − percentile(active_trials)
activity
96
burdenPercentile
30
activityPercentile
30

ranking row 2607951

14=Malignant Prostate Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
33881
formula
percentile(mortality_count) − percentile(active_trials)
activity
1375
burdenPercentile
86.7
activityPercentile
86.7

ranking row 2607955

14▲16Malignant Thyroid Gland Neoplasm056.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
2148
formula
percentile(mortality_count) − percentile(active_trials)
activity
176
burdenPercentile
33.3
activityPercentile
33.3

ranking row 2607954

19▲6Malignant Hypopharyngeal Neoplasm-3.340Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
483
formula
percentile(mortality_count) − percentile(active_trials)
activity
53
burdenPercentile
6.7
activityPercentile
10

ranking row 2607956

20▲1Malignant Breast Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
42724
formula
percentile(mortality_count) − percentile(active_trials)
activity
2627
burdenPercentile
93.3
activityPercentile
96.7

ranking row 2607957

20▲4Malignant Central Nervous System Neoplasm-3.436.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
18203
formula
percentile(mortality_count) − percentile(active_trials)
activity
823
burdenPercentile
73.3
activityPercentile
76.7

ranking row 2607958

22▲4Malignant Penile Neoplasm-6.730Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
358
formula
percentile(mortality_count) − percentile(active_trials)
activity
43
burdenPercentile
0
activityPercentile
6.7

ranking row 2607959

23▲3Leukemia-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
23589
formula
percentile(mortality_count) − percentile(active_trials)
activity
1769
burdenPercentile
80
activityPercentile
90

ranking row 2607960

23▲5Malignant Uterine Corpus Neoplasm-1026.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
8183
formula
percentile(mortality_count) − percentile(active_trials)
activity
411
burdenPercentile
43.3
activityPercentile
53.3

ranking row 2607961

25▲4Malignant Ovarian Neoplasm-13.320Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
12883
formula
percentile(mortality_count) − percentile(active_trials)
activity
684
burdenPercentile
56.7
activityPercentile
70

ranking row 2607962

26▲5Non-Hodgkin Lymphoma-16.616.7Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
19983
formula
percentile(mortality_count) − percentile(active_trials)
activity
2168
burdenPercentile
76.7
activityPercentile
93.3

ranking row 2607963

27▲5Malignant Gastric Neoplasm-16.713.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
10966
formula
percentile(mortality_count) − percentile(active_trials)
activity
652
burdenPercentile
50
activityPercentile
66.7

ranking row 2607964

28▲6Malignant Cervical Neoplasm-2010Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
4162
formula
percentile(mortality_count) − percentile(active_trials)
activity
505
burdenPercentile
40
activityPercentile
60

ranking row 2607966

28▲5Multiple Myeloma-2010Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
11577
formula
percentile(mortality_count) − percentile(active_trials)
activity
814
burdenPercentile
53.3
activityPercentile
73.3

ranking row 2607965

30▲5Hodgkin Lymphoma-203.3Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
1021
formula
percentile(mortality_count) − percentile(active_trials)
activity
179
burdenPercentile
16.7
activityPercentile
36.7

ranking row 2607967

31▲5Malignant Nasopharyngeal Neoplasm-300Medium confidencecdc-uscsclinicaltrialscdc-wonderseeriarc-globocan
inputs
deaths
693
formula
percentile(mortality_count) − percentile(active_trials)
activity
261
burdenPercentile
13.3
activityPercentile
43.3

ranking row 2607968

Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 62404bd64ab2fc14f6374d25